HSBC Holdings’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-119,006
Closed -$1.29M – 3062
2026
Q2
$1.29M Sell
119,006
-36,579
-24% -$283K ﹤0.01% 1802
2026
Q1
$976K Buy
155,585
+8,814
+6% +$61.3K ﹤0.01% 1873
2025
Q4
$1.03M Sell
146,771
-73,487
-33% -$443K ﹤0.01% 1927
2025
Q3
$1.2M Buy
220,258
+72,173
+49% +$354K ﹤0.01% 1726
2025
Q2
$751K Buy
148,085
+35,896
+32% +$215K ﹤0.01% 1947
2025
Q1
$743K Buy
112,189
+6,182
+6% +$47K ﹤0.01% 1886
2024
Q4
$789K Buy
106,007
+15,368
+17% +$110K ﹤0.01% 1925
2024
Q3
$632K Buy
90,639
+67,981
+300% +$409K ﹤0.01% 1899
2024
Q2
$110K Buy
22,658
+329
+1% +$1.98K ﹤0.01% 2714
2024
Q1
$138K Buy
22,329
+6,729
+43% +$45.3K ﹤0.01% 2772
2023
Q4
$123K Buy
+15,600
New +$101K ﹤0.01% 2565

Other funds holding LFST

HSBC Holdings's LFST Position: Q3 2026 in Review

HSBC Holdings sold out of Lifestance Health (LFST) in Q3 2026, closing a stake of 119,006 shares — an estimated $1.29M sold.

HSBC Holdings first reported a position in LFST in Q4 2023 and held it in 11 quarters. The position peaked at $1.29M in Q2 2026. 324 funds tracked by Wall St. Rank hold LFST as of Q3 2026.

  • HSBC Holdings reported no remaining Lifestance Health position as of Q3 2026 after selling out during the quarter.
  • HSBC Holdings sold 119,006 Lifestance Health shares in Q3 2026, an estimated $1.29M.
  • HSBC Holdings first reported a position in Lifestance Health in Q4 2023 and held it in 11 quarters.
  • HSBC Holdings's Lifestance Health position peaked at $1.29M in Q2 2026.
  • 324 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2026.

Based on HSBC Holdings's 13F filing for Q3 2026, filed 16 Nov 2026.